Walleye Capital’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-84,892
| Closed | -$895K | – | 2597 |
|
|
2023
Q1 | $895K | Buy |
84,892
+52,698
| +164% | +$556K | 0.01% | 781 |
|
|
2022
Q4 | $1.09M | Buy |
32,194
+611
| +2% | +$20.7K | 0.02% | 685 |
|
|
2022
Q3 | $1.52M | Sell |
31,583
-865
| -3% | -$41.5K | 0.03% | 550 |
|
|
2022
Q2 | $1.85M | Buy |
32,448
+7,468
| +30% | +$426K | 0.05% | 378 |
|
|
2022
Q1 | $2.02M | Buy |
+24,980
| New | +$2.02M | 0.05% | 359 |
|
|
2021
Q4 | – | Sell |
-872
| Closed | -$235 | – | 2185 |
|
|
2021
Q3 | $235 | Buy |
+872
| New | +$235 | 0.01% | 1109 |
|
|
2021
Q1 | – | Sell |
-1,440
| Closed | -$367 | – | 1276 |
|
|
2020
Q4 | $367 | Buy |
+1,440
| New | +$367 | 0.02% | 559 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 943 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 829 |
|